Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Varenicline Pre-treatment for Smoking Cessation
NCT00789074Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Jul 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of varenicline in tobacco dependence (2 arms), sponsored by Queen Mary University of London. Primary endpoint: Rating of Urges to Smoke. Started Jul 2009; status: completed.
02
Drugs
varenicline
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT00789074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789074.